| RFC1 |
IPI00375359 |
PTMA |
IPI00015550 |
0.645 |
Evidence |
|
| MCM7 |
MCM7, CDC47, MCM2: DNA replication licensing factor MCM7 |
TCOF1 |
IPI00298696 |
0.645 |
Evidence |
|
| RPA1 |
RPA1, REPA1, RPA70: Replication protein A 70 kDa DNA-binding subunit |
MAP2K3 |
MAP2K3, MEK3, MKK3, PRKMK3: Dual specificity mitogen-activated protein kinase ki |
0.645 |
Evidence |
|
| FLNA |
FLNA, FLN, FLN1: Filamin-A |
ARHGDIA |
ARHGDIA, GDIA1: Rho GDP-dissociation inhibitor 1 |
0.645 |
Evidence |
|
| UBTF |
UBTF, UBF, UBF1: Nucleolar transcription factor 1 |
DUSP2 |
DUSP2, PAC1: Dual specificity protein phosphatase 2 |
0.645 |
Evidence |
|
| CA6 |
CA6: Carbonic anhydrase 6 precursor |
SLC4A7 |
SLC4A7: Uncharacterized protein SLC4A7 |
0.645 |
Evidence |
|
| SLC4A1 |
SLC4A1, AE1, DI, EPB3: Band 3 anion transport protein |
CA6 |
CA6: Carbonic anhydrase 6 precursor |
0.645 |
Evidence |
|
| VPS4A |
VPS4A, VPS4: Vacuolar protein sorting-associating protein 4A |
CBFB |
Core binding factor beta isoform PEBP2B |
0.645 |
Evidence |
|
| RBBP7 |
RBBP7, RBAP46: Histone-binding protein RBBP7 |
BRMS1 |
BRMS1: Breast cancer metastasis-suppressor 1 |
0.645 |
Evidence |
|
| UBTF |
UBTF, UBF, UBF1: Nucleolar transcription factor 1 |
CKS1B |
CKS1B, CKS1, PNAS-16, PNAS-143: Cyclin-dependent kinases regulatory subunit 1 |
0.645 |
Evidence |
|
| PAX5 |
PAX5: Paired box protein Pax-5 |
STAT4 |
STAT4: Signal transducer and activator of transcription 4 |
0.642 |
Evidence |
|
| CALM2 |
CALM1, CALM, CALM2, CAM2, CALM3, CALML2, CAM, CAMB, CAM3, CAM1, CAMC, CAMIII: Ca |
NFKBIE |
NFKBIE, IKBE: NF-kappa-B inhibitor epsilon |
0.642 |
Evidence |
|
| GPR1 |
GPR1: Probable G-protein coupled receptor 1 |
GPR88 |
GPR88, STRG: Probable G-protein coupled receptor 88 |
0.642 |
Evidence |
|
| ID1 |
ID1, ID: DNA-binding protein inhibitor ID-1 |
CREBBP |
CREBBP, CBP: CREB-binding protein |
0.642 |
Evidence |
|
| CCND2 |
CCND2: G1/S-specific cyclin-D2 |
CEBPA |
CEBPA: CCAAT/enhancer-binding protein alpha |
0.642 |
Evidence |
|
| NPY1R |
NPY1R, NPYR, NPYY1: Neuropeptide Y receptor type 1 |
NPY2R |
NPY2R: Neuropeptide Y receptor type 2 |
0.642 |
Evidence |
|
| C5AR1 |
C5AR1, C5AR, C5R1: C5a anaphylatoxin chemotactic receptor |
C14orf21 |
LTB4R2, BLT2R, BLTR2: Leukotriene B4 receptor 2 |
0.642 |
Evidence |
|
| C5AR1 |
C5AR1, C5AR, C5R1: C5a anaphylatoxin chemotactic receptor |
MTNR1A |
MTNR1A: Melatonin receptor type 1A |
0.642 |
Evidence |
|
| C5AR1 |
C5AR1, C5AR, C5R1: C5a anaphylatoxin chemotactic receptor |
EDNRA |
EDNRA, ETA, ETRA: Endothelin-1 receptor precursor |
0.642 |
Evidence |
|
| C5AR1 |
C5AR1, C5AR, C5R1: C5a anaphylatoxin chemotactic receptor |
LHCGR |
LHCGR, LCGR, LGR2, LHRHR: Lutropin-choriogonadotropic hormone receptor precursor |
0.642 |
Evidence |
|
| FPR1 |
FPR1: fMet-Leu-Phe receptor |
C14orf21 |
LTB4R2, BLT2R, BLTR2: Leukotriene B4 receptor 2 |
0.642 |
Evidence |
|
| FPR1 |
FPR1: fMet-Leu-Phe receptor |
MTNR1A |
MTNR1A: Melatonin receptor type 1A |
0.642 |
Evidence |
|
| FPR1 |
FPR1: fMet-Leu-Phe receptor |
EDNRA |
EDNRA, ETA, ETRA: Endothelin-1 receptor precursor |
0.642 |
Evidence |
|
| FPR1 |
FPR1: fMet-Leu-Phe receptor |
LHCGR |
LHCGR, LCGR, LGR2, LHRHR: Lutropin-choriogonadotropic hormone receptor precursor |
0.642 |
Evidence |
|
| TNFRSF1B |
TNFRSF1B, TNFBR, TNFR2: Tumor necrosis factor receptor superfamily member 1B pre |
TNFRSF9 |
TNFRSF9, CD137, ILA: Tumor necrosis factor receptor superfamily member 9 precurs |
0.642 |
Evidence |
|